SCHEMBL771200

SCHEMBL771200

OC1C(O)C2C3CCC(C3)C12

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10397673 0.84
SCHEMBL9227363 0.81 LMNA (0.39) CYP2C9
SCHEMBL9252008 0.81 LMNA (0.39) CYP2C9
SCHEMBL25795447 0.78 CYP2C9 (0.30) CYP2C9
SCHEMBL14123432 0.78 CYP2C9 (0.30) CYP2C9
SCHEMBL27053450 0.78 CYP2C9 (0.30) CYP2C9
SCHEMBL27053446 0.78 CYP2C9 (0.30) CYP2C9
SCHEMBL10035514 0.77
SCHEMBL278804 0.77
SCHEMBL1127899 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 334 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3514189-B1 SOLVENT-FREE MULTICOMPONENT SYSTEM EVONIK OPERATIONS GMBH (DE) 2023-07-26 EP claimed
US-10336856-B2 Alkoxysilane- and allophanate-functionalized coating materials EVONIK DEGUSSA GMBH (DE) 2019-07-02 US claimed
US-10336854-B2 Alkoxysilane-functionalized and allophanate-functionalized urethanes EVONIK DEGUSSA GMBH (DE) 2019-07-02 US claimed
EP-3122447-B1 DISPERSING RESINS EVONIK DEGUSSA GMBH (DE) 2018-10-17 EP claimed
US-10010838-B2 Dispersing resins EVONIK DEGUSSA GMBH (DE) 2018-07-03 US claimed
US-20180028994-A1 DISPERSING RESINS EVONIK DEGUSSA GMBH (DE) 2018-02-01 US claimed
US-20170369631-A1 ALKOXYSILANE- AND ALLOPHANATE-FUNCTIONALIZED COATING MATERIALS EVONIK DEGUSSA GMBH (DE) 2017-12-28 US claimed
US-20170369627-A1 ALKOXYSILANE-FUNCTIONALIZED AND ALLOPHANATE-FUNCTIONALIZED URETHANES EVONIK DEGUSSA GMBH (DE) 2017-12-28 US claimed
US-20160152825-A1 PROCESS FOR PRODUCING COMPOSITES EVONIK DEGUSSA GMBH (DE) 2016-06-02 US claimed
CN-101210151-B method for coating metal strip EVONIK DEGUSSA GMBH (DE) 2014-10-22 CN claimed
US-20040122172-A1 Polymer-modified resins DEGUSSA AG (DE) 2004-06-24 US claimed
US-20040116604-A1 Polymer-modified resins DEGUSSA AG (DE) 2004-06-17 US claimed
US-20040054075-A1 Adhesion promoter additive comprising an unsaturated, amorphous polyester DEGUSSA AG (DE) 2004-03-18 US claimed
EP-0558907-B1 Aqueous coating compositions from polyethylene terephthalate SHERWIN WILLIAMS CO (US) 1996-06-19 EP claimed
US-5371112-A Acidolysis THE SHERWIN-WILLIAMS COMPANY (US) 1994-12-06 US claimed
US-5252615-A Aqueous coating compositions from polyethylene terephthalate THE SHERWIN-WILLIAMS COMPANY (US) 1993-10-12 US claimed
EP-0558907-A1 Aqueous coating compositions from polyethylene terephthalate THE SHERWIN-WILLIAMS COMPANY (US) 1993-09-08 EP claimed
EP-0558905-A1 Aqueous coating compositions from polyethylene terephthalate THE SHERWIN-WILLIAMS COMPANY (US) 1993-09-08 EP claimed
EP-0558906-A1 Non-aqueous coating compositions from polyethylene terephthalate THE SHERWIN-WILLIAMS COMPANY (US) 1993-09-08 EP claimed
EP-0556592-A1 Non-aqueous coating compositions from polyethylene terephthalate THE SHERWIN-WILLIAMS COMPANY (US) 1993-08-25 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10336856-B2 Alkoxysilane- and allophanate-functionalized coating materials DDAH1, OR10J3, AP3S1 CYP2C9 1933/4885
US-10336854-B2 Alkoxysilane-functionalized and allophanate-functionalized urethanes ALKBH3, PUF60, SDC2 CYP2C9 2236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.